Via Care Community Health Center
Via Care Community Health Center was paid $39.65M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoVIA CARE COMMUNITY HEALTH CENTER
LOS ANGELES, CA 90022
LOS ANGELES, CA 90022
33aNPI1497001226assigned 07/30/2012
33bProvider typeCase Manager/Care Coordinator
28Total paid$39.65M
24GClaims762,692
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Manager/Care Coordinator providers in California
Rank by total paid#50 of 435
Median peer was paid$2.89M
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,233 | $3.17M | |
| 2019 | 31,816 | $2.52M | |
| 2020 | 76,209 | $3.86M | |
| 2021 | 164,415 | $8.12M | |
| 2022 | 145,523 | $6.71M | |
| 2023 | 202,007 | $10.21M | |
| 2024incomplete | 116,489 | $5.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 205,061 | 150,804 | $32.45M |
| 00003 | Internal/system code - not a standard HCPCS code | 13% | 26,724 | 21,794 | $5.08M |
| G9012 | Other specified case management service not elsewhere classified | 1.7% | 22,851 | 10,029 | $669K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.4% | 108,832 | 76,993 | $539K |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 8,167 | 4,379 | $292K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 55,839 | 41,268 | $146K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 8,025 | 2,736 | $83K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 3,035 | 1,832 | $48K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 6,008 | 2,741 | $38K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 4,240 | 3,822 | $34K |
| 0011A | <1% | 727 | 423 | $29K | |
| 0002A | <1% | 552 | 354 | $24K |
196 more codes
| 0012A | <1% | 553 | $22K | |
| G9920 | Screening performed and negative | <1% | 8,634 | $22K |
| 0001A | <1% | 444 | $22K | |
| 99401 | <1% | 1,596 | $19K | |
| 90686 | <1% | 4,091 | $11K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,014 | $11K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 12,408 | $10K |
| 0013A | <1% | 186 | $8K | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 56 | $7K |
| 0003A | <1% | 142 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,641 | $7K |
| J3490 | Unclassified drugs | <1% | 88 | $6K |
| 92551 | <1% | 6,812 | $5K | |
| 90746 | <1% | 192 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,941 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,063 | $5K |
| 90688 | <1% | 775 | $4K | |
| 0072A | <1% | 136 | $4K | |
| 99000 | <1% | 16,823 | $3K | |
| H0049 | Alcohol and/or drug screening | <1% | 945 | $3K |
| 0071A | <1% | 70 | $3K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 546 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 728 | $2K |
| 90670 | <1% | 2,144 | $2K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 246 | $2K |
| G0467 | Community health center visit, returning patient | <1% | 368 | $2K |
| 0031A | <1% | 41 | $2K | |
| 81025 | <1% | 2,623 | $2K | |
| 85018 | <1% | 12,827 | $2K | |
| 90647 | <1% | 1,721 | $1K | |
| 90723 | <1% | 1,723 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,492 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,310 | $1K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 233 | $975.00 |
| D1310 | <1% | 1,013 | $966.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,801 | $804.23 |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 506 | $658.80 |
| 90633 | <1% | 789 | $630.00 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 116 | $615.36 |
| 90677 | <1% | 330 | $585.00 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 180 | $540.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 85 | $459.17 |
| 81000 | <1% | 16,181 | $272.72 | |
| 90681 | <1% | 428 | $270.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,497 | $211.98 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,291 | $208.66 |
| 90651 | <1% | 310 | $207.00 | |
| 0124A | <1% | 35 | $201.00 | |
| 90655 | <1% | 120 | $198.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 6,906 | $150.89 |
| D0602 | <1% | 599 | $150.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 2,242 | $147.96 |
| 90734 | <1% | 114 | $117.00 | |
| 88174 | <1% | 349 | $113.44 | |
| 99173 | <1% | 13,454 | $113.41 | |
| 83655 | <1% | 728 | $95.80 | |
| D1206 | Topical application of fluoride varnish | <1% | 31 | $82.00 |
| 90715 | <1% | 235 | $81.00 | |
| 90716 | <1% | 186 | $63.00 | |
| 82948 | <1% | 5,035 | $58.85 | |
| 86703 | <1% | 1,654 | $50.24 | |
| 99201 | <1% | 119 | $47.88 | |
| 96127 | <1% | 257 | $45.70 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,764 | $43.51 |
| D0603 | <1% | 90 | $30.00 | |
| 97803 | <1% | 246 | $25.23 | |
| 90707 | <1% | 120 | $18.00 | |
| 80061 | Lipid panel | <1% | 4,827 | $10.60 |
| 90700 | <1% | 126 | $9.00 | |
| 86592 | <1% | 1,597 | $5.77 | |
| 36416 | 0% | 16,550 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 2,606 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 4,045 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 2,492 | $0.00 |
| 1036F | 0% | 5,732 | $0.00 | |
| 3079F | 0% | 693 | $0.00 | |
| 99383 | 0% | 196 | $0.00 | |
| 3008F | 0% | 42,245 | $0.00 | |
| Z1034 | 0% | 4,773 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 4,285 | $0.00 |
| Z6410 | 0% | 3,280 | $0.00 | |
| 81001 | 0% | 1,032 | $0.00 | |
| 1000F | 0% | 3,617 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 5,616 | $0.00 |
| 96156 | 0% | 510 | $0.00 | |
| 3074F | 0% | 1,762 | $0.00 | |
| Z6204 | 0% | 1,765 | $0.00 | |
| 86780 | 0% | 269 | $0.00 | |
| Z6406 | 0% | 628 | $0.00 | |
| 85027 | 0% | 15 | $0.00 | |
| 88142 | 0% | 702 | $0.00 | |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 71 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 272 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 909 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 336 | $0.00 |
| 87625 | 0% | 36 | $0.00 | |
| 80055 | 0% | 44 | $0.00 | |
| D1330 | 0% | 1,069 | $0.00 | |
| 99385 | 0% | 133 | $0.00 | |
| Z6402 | 0% | 647 | $0.00 | |
| 84479 | 0% | 113 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 28 | $0.00 |
| 84436 | 0% | 237 | $0.00 | |
| 86803 | 0% | 760 | $0.00 | |
| 87081 | 0% | 200 | $0.00 | |
| Z1032 | 0% | 243 | $0.00 | |
| 86580 | 0% | 82 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 95 | $0.00 |
| 3080F | 0% | 126 | $0.00 | |
| 1034F | 0% | 887 | $0.00 | |
| 99381 | 0% | 83 | $0.00 | |
| 82043 | 0% | 69 | $0.00 | |
| 91307 | 0% | 49 | $0.00 | |
| 3075F | 0% | 302 | $0.00 | |
| 87807 | 0% | 51 | $0.00 | |
| 3072F | 0% | 15 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 16 | $0.00 |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 26 | $0.00 |
| G9007 | Coordinated care fee, scheduled team conference | 0% | 317 | $0.00 |
| 82962 | 0% | 24 | $0.00 | |
| 96151 | 0% | 14 | $0.00 | |
| 3014F | 0% | 33 | $0.00 | |
| 1126F | 0% | 133 | $0.00 | |
| 90680 | 0% | 16 | $0.00 | |
| 99384 | 0% | 56 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 26 | $0.00 |
| 84153 | 0% | 12 | $0.00 | |
| 82950 | 0% | 41 | $0.00 | |
| 80069 | 0% | 12 | $0.00 | |
| 97802 | 0% | 15 | $0.00 | |
| 3351F | 0% | 109 | $0.00 | |
| 99386 | 0% | 45 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 54 | $0.00 |
| 88720 | 0% | 13 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 87 | $0.00 |
| 59430 | 0% | 21 | $0.00 | |
| 90480 | 0% | 20 | $0.00 | |
| 92060 | 0% | 17 | $0.00 | |
| 80051 | 0% | 15 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 26 | $0.00 |
| Z6400 | 0% | 1,876 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 2,453 | $0.00 |
| 3078F | 0% | 2,164 | $0.00 | |
| 3725F | 0% | 13,920 | $0.00 | |
| Z6414 | 0% | 435 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 717 | $0.00 |
| 2028F | 0% | 1,612 | $0.00 | |
| Z6300 | 0% | 662 | $0.00 | |
| D0190 | 0% | 463 | $0.00 | |
| 11721 | 0% | 51 | $0.00 | |
| 4004F | 0% | 885 | $0.00 | |
| 80305 | 0% | 270 | $0.00 | |
| 90661 | 0% | 13 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 22 | $0.00 |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 503 | $0.00 |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 24 | $0.00 |
| 0502F | 0% | 216 | $0.00 | |
| Z6308 | 0% | 196 | $0.00 | |
| D9993 | 0% | 1,034 | $0.00 | |
| 96160 | 0% | 617 | $0.00 | |
| 3077F | 0% | 650 | $0.00 | |
| Z6200 | 0% | 725 | $0.00 | |
| 84442 | 0% | 319 | $0.00 | |
| 90836 | 0% | 38 | $0.00 | |
| Z6208 | 0% | 273 | $0.00 | |
| 91300 | 0% | 83 | $0.00 | |
| 03 | Instill, bupivac and meloxic | 0% | 2,523 | $0.00 |
| 91312 | 0% | 41 | $0.00 | |
| 90461 | 0% | 35 | $0.00 | |
| 3046F | 0% | 64 | $0.00 | |
| 1160F | 0% | 48 | $0.00 | |
| 80074 | 0% | 95 | $0.00 | |
| Z6304 | 0% | 838 | $0.00 | |
| 83540 | 0% | 29 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 44 | $0.00 |
| Z6202 | 0% | 73 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 122 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 12 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 179 | $0.00 |
| H1002 | Prenatal care, at risk enhanced service; care coordination | 0% | 17 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 64 | $0.00 |
| 87481 | 0% | 13 | $0.00 | |
| 86480 | 0% | 69 | $0.00 | |
| 1158F | 0% | 84 | $0.00 | |
| 81003 | 0% | 44 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 54 | $0.00 |
| 83013 | 0% | 14 | $0.00 | |
| 91320 | 0% | 20 | $0.00 | |
| 82570 | 0% | 20 | $0.00 | |
| 80076 | 0% | 14 | $0.00 | |
| Z6500 | 0% | 12 | $0.00 | |
| H0019 | Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | 0% | 21 | $0.00 |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | 0% | 21 | $0.00 |
| 87535 | 0% | 12 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 25 | $0.00 |
| 99382 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFALCETTI, NINA (DIRECTOR OF HR)